SCHEMBL15067284

SCHEMBL15067284

COc1ccc(C=O)c(-c2ccc(CCCN(C)C)nc2)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.40
▸ TRIM24 O15164 1/20 0.40
▸ TYR P14679 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40
▸ CTSA P10619 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ MCHR1 Q99705 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ ERN1 O75460 2/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ TOP1 P11387 1/20 0.37
▸ APP P05067 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15067763 0.85 HTR2A (0.37) ATMHTR2AHTR2CHTR2BERN1
SCHEMBL15067149 0.72 RXFP1 (0.52) ALDH1A1
SCHEMBL30839665 0.69 HRH3 (0.40) ALDH1A1KDM4E
SCHEMBL21541905 0.69 HRH3 (0.40) ALDH1A1KDM4E
SCHEMBL11369904 0.69 KDM4E (0.50) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL4845712 0.68 HTR7 (0.47) ALDH1A1ERN1KDM4EMAOB
SCHEMBL19153327 0.67 ALDH1A1 (0.53) TRIM24TYRTRIM33CTSAALDH1A1
SCHEMBL4392162 0.67 ALDH1A1 (0.53) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL18284498 0.67 ALDH1A1 (0.53) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL4729218 0.67 CHRNB2 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797889-A1 NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS Centaurus Biopharma Co., Ltd. (CN) 2014-11-05 — — EP disclosed
WO-2013097773-A1 NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2013-07-04 — — WO disclosed
Send feedback